Ethylenediaminetetraacetic Acid Enhances Vancomycin and Reactive Oxygen Species–Mediated Killing of Vancomycin-Intermediate Staphylococcus aureus - Takeaways - MDSpire

Ethylenediaminetetraacetic Acid Enhances Vancomycin and Reactive Oxygen Species–Mediated Killing of Vancomycin-Intermediate Staphylococcus aureus

  • By

  • Joshua Olson

  • Anuj K Khetarpal

  • Allen Jankeel

  • Arianna Lorenzana

  • Victor Nizet

  • George Sakoulas

  • Erlinda R Ulloa

  • May 13, 2025

  • 0 min

Share

  • 1

    Ethylenediaminetetraacetic acid (EDTA) enhances the efficacy of vancomycin against vancomycin-intermediate Staphylococcus aureus (VISA) infections.

  • 2

    VISA strains exhibit mutations in Krebs cycle enzymes, promoting anaerobic metabolism and reducing susceptibility to antibiotics.

  • 3

    EDTA improves hydrogen peroxide-mediated killing of VISA, enhancing neutrophil killing more effectively than vancomycin alone.

  • 4

    In vivo studies demonstrate that EDTA significantly enhances the activity of vancomycin against VISA.

  • 5

    The study highlights the need for new strategies to combat antibiotic tolerance in VISA, focusing on EDTA's role in potentiating reactive oxygen species.

Original Source(s)

Ethylenediaminetetraacetic Acid Enhances Vancomycin and Reactive Oxygen Species–Mediated Killing of Vancomycin-Intermediate Staphylococcus aureus

  • by Joshua Olson, Anuj K Khetarpal, Allen Jankeel, Arianna Lorenzana, Victor Nizet, George Sakoulas, Erlinda R Ulloa

  • May 13, 2025

Related Content

Immune imbalance markers: key factors in early recognition of multidrug-resistant bacterial infections in non-immunocompromised VAP patients

Connecting the Diagnostic Dots in HIES

Clinical case report highlights how classic features of STAT3 hyper-IgE syndrome can be routinely missed in pediatric practice

Staphylococcus aureus serine protease-like protein B elicits a type 1/type 2 immune response in atopic dermatitis patients